ERBB2 and breast cancer: The EndoPredict (EP) assay is an RT-qPCR-based 12-gene test based on RNA from FFPE tissue in hormone receptor-positive, HER2-negative, nodal-negative and -positive BC managed with adjuvant hormonal treatment alone [17] that has been designed to integrate genomic and clinical information.